Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2010
12/08/2010CN101906438A Method for expressing and producing recombinant human blood coagulation factors VII in animal cells
12/08/2010CN101906437A Method for expressing and producing recombinant human blood coagulation factors VIII in animal cells
12/08/2010CN101906436A Vector system pGN for high-level expression of recombinant glycoprotein in CHO (Chinese Hamster Ovary) cell
12/08/2010CN101906435A Vector system pSA for high-level expression of recombinant glycoprotein in eukaryotic cells
12/08/2010CN101906418A Promoter for introducing gene into lymphocyte or blood cell and application thereof
12/08/2010CN101906413A Heterologous expression of neisserial proteins
12/08/2010CN101906154A Protein for adjusting green turning process of plant leave as well as coding gene and application thereof
12/08/2010CN101906135A Novel spirulina source antihypertensive peptide and preparation method thereof
12/08/2010CN101532016B A section of DNA molecule, recombination expression vector containing the DNA molecule and use thereof
12/08/2010CN101531700B Maize oligopeptide preparing method
12/08/2010CN101210050B Antibodies for preventing bloodvessel endothelium growth factor
12/08/2010CN101182357B Globefish skin active collagen and method for preparing peptide thereof
12/08/2010CN101143892B Method for resolving enantiomer by enzyme catalysis
12/08/2010CN101044239B Mammalian cell culture processes for protein production
12/07/2010US7847081 novel B7-H3 and B7-H4 polypeptides useful for co-stimulating T cells, vectors containing the nucleic acid molecules, and cells containing the vectors
12/07/2010US7847079 Albumin fusion proteins
12/07/2010US7847070 to identify antagonists of human antigen LUCA2 a disease and cancer-associated antigen; anticancer agents
12/07/2010US7847069 small ubiquitin-like modifier (SUMO); for diagnosis and treatment of Type 1 diabetes
12/07/2010US7847068 Neutralizing human anti-IGFR antibody
12/07/2010US7846737 Genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
12/07/2010US7846732 Sequence specific DNA recombination in eukaryotic cells
12/07/2010US7846719 comprises a sequence encoding glutaminyl cyclase (QC), a fusion protein tag upstream of the sequence encoding QC, and a linker region having at least one (His)x-tag between the sequence encoding QC and the fusion protein tag
12/07/2010US7846710 cell comprising a polypeptide comprising a carboxy-terminal portion of a split intein (C-intein), an amino-terminal portion of a split intein (N-intein), and a target peptide; utilize the trans-splicing ability of split inteins to catalyze cyclization of peptides from a precursor peptide
12/07/2010US7846704 Flap endonuclease mutants
12/07/2010US7846700 Method for preparing transformants expressing benzaldehyde dehydrogenase and preparation of 2,6-naphthalene dicarboxylic acid using the transformants
12/07/2010US7846698 Method of producing L-lysine
12/07/2010US7846694 Using polymerase chain reaction to amplify preferential DNA sequences for use directed translation events
12/07/2010US7846692 HE4 monoclonal antibodies and methods for their use
12/07/2010US7846689 Translation biochemistry and directed protein evolution
12/07/2010US7846687 Modified viral sequences which enhance genic expression in microorganismal host
12/07/2010US7846673 Blot analysis of urine/serum; proteoglycan-like domains; oncogenes; hybridomas
12/07/2010US7846453 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3
12/07/2010US7846451 Chimeric outermembrane polypeptide for use as tool in diagnosis and treatment of parasitic infection
12/07/2010US7846441 Treatment with anti-ErbB2 antibodies
12/07/2010US7846437 Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same
12/07/2010US7846435 Humanized antibodies that recognize Verotoxin II and cell line producing same
12/07/2010US7846431 Composition comprising hyaluronidase glycoprotein that is active at neutral pH and contains at least one sugar moiety that is covalently attached to an asparagine for use in treatment of diabetic disorders
12/07/2010CA2417570C Tumor-specific t cell activation by peptide antigens
12/07/2010CA2153653C Growth differentiation factor-9
12/02/2010WO2010138769A1 Amino acid sequences which enhance peptide conjugate solubility
12/02/2010WO2010138502A2 Production of glycoproteins
12/02/2010WO2010138123A1 P53 fusion proteins and methods of making and using thereof
12/02/2010WO2010137624A1 Process for production of useful substance, and surfactant for use in the process
12/02/2010WO2010137489A1 Glucose dehydrogenase having altered properties
12/02/2010WO2010118324A3 Antibodies against fatty acid synthase
12/02/2010WO2010118203A3 Endosialin binding molecules
12/02/2010US20100306881 improved ability to enzymatically degrade lignocellulosic feedstock; fermentation
12/02/2010US20100306880 Nucleic acids for inducing expression of transcripts and proteins and methods for making and using them
12/02/2010US20100306879 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
12/02/2010US20100306864 Polypeptide having enhanced effector function
12/02/2010US20100306863 Screening, therapy and diagnosis
12/02/2010US20100305306 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
12/02/2010US20100305227 Protein-Containing Foams, Manufacture and Use Thereof
12/02/2010US20100305194 Modified and stabilized gdf propeptides and uses thereof
12/02/2010US20100305041 Cell permeable p18 recombinant proteins, polynucleotides encoding the same, and anticancer composition comprising the same
12/02/2010US20100305040 Production of soluble recombinant protein by pi value control of n-terminal
12/02/2010US20100305003 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/02/2010US20100304476 Expression of Human Serum Albumin in Plastids
12/02/2010US20100304436 Fucosylation-Deficient Cells
12/02/2010US20100304435 Fluorescent proteins, their production and use
12/02/2010US20100304434 Polypeptides having Cellulolytic Enhancing Activity and Polynucleotides Encoding Same
12/02/2010US20100304433 Polypeptides Having Protease Activity and Polynucleotides Encoding Same
12/02/2010US20100304432 Genetically modified biological cells
12/02/2010US20100304431 tRNA SYNTHESIS METHOD, NUCLEIC ACID, AMINOACYL tRNA SYNTHESIS METHOD, AND PROCESS FOR PRODUCTION OF PROTEIN INTRODUCED WITH UNNATURAL AMINO ACID
12/02/2010US20100304430 Methods for Generating Analogs of Coenzyme A
12/02/2010US20100304402 Chimeric human sweet-umami and umami-sweet taste receptors
12/02/2010US20100304382 Gene Defects and Mutant ALK Kinase in Human Solid Tumors
12/02/2010US20100303897 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
12/02/2010US20100303856 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
12/02/2010US20100303849 Lipidated Vaccine against Dengue Virus Infection
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303818 Dendritic cell receptor
12/02/2010US20100303812 Neutralizing monoclonal antibody against human dll4
12/02/2010US20100303797 Use of p97 As An Enzyme Delivery System For The Delivery of Therapeutic Lysosomal Enzymes
12/02/2010US20100303729 Cyanochrome fluorophores
12/02/2010US20100303726 Humanized collagen antibodies and related methods
12/02/2010CA2799608A1 Amino acid sequences which enhance peptide conjugate solubility
12/02/2010CA2763464A1 Utilization of pharmacological chaperones to improve manufacturing and purification of biologics
12/02/2010CA2761817A1 Production of glycoproteins
12/01/2010EP2256211A2 Fermentative production of valuable compounds on an industrial scale using chemically defined media
12/01/2010EP2256205A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/01/2010EP2256204A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/01/2010EP2256202A2 Stimulus-inducible i (kappa)b kinase ikk signalsome
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2255679A1 Yeast extract including disodium inosinate salt and disodium guanylate salt and producing method thereof
12/01/2010EP1935981B1 Process for producing recombinant protein
12/01/2010EP1930428B1 transformed yeast host cells AND METHOD OF PRODUCING FOREIGN PROTEIN
12/01/2010EP1863920B1 Method for improved isolation of recombinantly produced proteins
12/01/2010EP1561807B1 Method of degrading hardly degradable protein
12/01/2010EP1536004B1 Method of promoting homologous recombination of somatic cells and method of constructing specific antibody
12/01/2010EP1449850B1 Human cdr-grafted antibodies and antibody fragments thereof
12/01/2010EP1414861B1 Humanized antibodies against icam-1, their production and uses
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010CN1856569B Animal product free process for obtaining a botulinum toxin and culture medium
12/01/2010CN1683550B Collagen and its preparing process
12/01/2010CN1646154B Albumin-fused anti-angiogenesis peptides
12/01/2010CN101903531A Yeast strains for protein production
12/01/2010CN101903530A Microorganism engineered to produce isopropanol
12/01/2010CN101903529A SM-protein based secretion engineering
12/01/2010CN101899491A Method for preparing micromolecular collagen peptide from fish scales by utilizing complex enzyme
1 ... 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 ... 1125